Syndrome of inappropriate antidiuretic hormone associated with moxifloxacin

American Journal of Health-System Pharmacy

Volumn 69, Issue 3, 2012, Pages 217-220

  Yam, Felix K ^a   Eraly, Satish A ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hyponatremia; Inappropriate ADH syndrome; Moxifloxacin; Prednisone; Pulmonary disease; Quinolones; Steroids, cortico ; Toxicity

Indexed keywords

ACETYLSALICYLIC ACID; CARVEDILOL; FOSINOPRIL; FUROSEMIDE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL; MOXIFLOXACIN; PREDNISONE; SIMVASTATIN; SODIUM;

AGED; ARTICLE; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DIZZINESS; DRUG WITHDRAWAL; EMERGENCY CARE; FEMALE; FOLLOW UP; HEADACHE; HOSPITALIZATION; HUMAN; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; PRIORITY JOURNAL; SODIUM BLOOD LEVEL;

EID: 84857597686     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp110201     Document Type: Article

References (16)

1. Bolon MK. The newer fluoroquinolones. Infect Dis Clin North Am. 2009; 23:1027-51.
2. Liu HH. Safety profile of the fluoroquinolones: focus on levofloxacin. Drug Saf. 2010; 33:353-69.
3. Kushner JM, Peckman HJ, Snyder CR. Seizures associated with fluoroquinolones. Ann Pharmacother. 2001; 35:1194-8. (Pubitemid 32959185)
4. Mussig K, Schnauder G, Morike K. Severe and symptomatic hyponatraemia after moxifloxacin intake. Neth J Med. 2009; 67:197.
5. Adler D, Voide C, Thorens JB et al. SIADH consecutive to ciprofloxacin intake. Eur J Intern Med. 2004; 15:463-4. (Pubitemid 39586713)
6. Liamis G, Milionis H, Elisaf M. A review of drug-induced hyponatremia. Am J Kidney Dis. 2008; 52:144-53. (Pubitemid 351853264)
7. Ghali JK. Mechanisms, risks, and new treatment options for hyponatremia. Cardiology. 2008; 111:147-57.
8. Chatterjee K. Hyponatremia in heart failure. J Intensive Care Med. 2009; 24:347-51.
9. Spital A. Diuretic-induced hyponatremia. Am J Nephrol. 1999; 19:447-52. (Pubitemid 29397071)
10. Byatt CM, Millard PH, Levin GE. Diuretics and electrolyte disturbances in 1000 consecutive geriatric admissions. J R Soc Med. 1990; 83:704-8. (Pubitemid 20361564)
11. Zhanel GG, Ennis K, Vercaigne L et al. A critical review of the fluoroquinolones: focus on respiratory infections. Drugs. 2002; 62:13-59. (Pubitemid 34169425)
12. Schmuck G, Schurmann A, Schluter G. Determination of the excitatory potencies of fluoroquinolones in the central nervous system by an in vitro model. Antimicrob Agents Chemother. 1998; 42:1831-6. (Pubitemid 28311587)
13. Kanellakopoulou K, Pagoulatou A, Stroumpoulis K et al. Pharmacokinetics of moxifloxacin in non-inflamed cerebrospinal fluid of humans: implication for a bactericidal effect. J Antimicrob Chemother. 2008; 61:1328-31. (Pubitemid 351753602)
14. Morris JF, Christian H, Ma D et al. Dendritic secretion of peptides from hypothalamic magnocellular neurosecretory neurones: a local dynamic control system and its functions. Exp Physiol. 2000; 85 Spec No:131S-138S. (Pubitemid 30182274)
15. Kengne FG, Decaux G. Inappropriate secretion of ADH and central diabetes insipidus are related to antiphospholipid antibodies in SLE - case report and review of the literature. Nephrol Dial Transplant. 2006; 21:3311-5.
16. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30:239-45. (Pubitemid 12149145)